missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Doxorubicinhydrochlorid, LoGiCal
Specifica
Specifica
| Chemischer Name oder Material | Doxorubicin Hydrochloride |
| CAS | 25316-40-9 |
| Bezeichnung der Analyten oder Bestandteile | Doxorubicin Hydrochloride |
| Versandbedingung | Raumtemperatur |
| Summenformel | C27 H29 N O11 . Cl H |
| Zertifizierung/Konformität | ISO 9001 |
| Synonym | Daunorubicin Hydrochloride Imp. D (EP), Daunorubicin Imp. D (EP), Epirubicin Hydrochloride Imp. C (EP), Epirubicin Imp. C (EP), 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S,10S)-, 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)-, Adriamycin, hydrochloride, ADM hydrochloride, ADR, Adriablastina CS, Adriacin, Adriamycin, Adriblastin, Adriblastina, Adriblastina RD, DOX HCl, Doxorubicin Hydrochloride, FI 106, FI 6804, Hydroxydaunorubicin hydrochloride, Lipo-Dox, Daunorubicin Hydrochloride Impurity D as Hydrochloride, Epirubicin Hydrochloride Impurity C as Hydrochloride, Daunorubicin Impurity D as Hydrochloride, Epirubicin Impurity C as Hydrochloride |
| InChI-Formel | InChI=1S/C27H29NO11.ClH/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34;/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3;1H/t10-,13-,15-,17-,22+,27-;/m0./s1 |
| Lösungstyp | Unverdünnt |
| SMILES | Cl.COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO |
| Vedi altri risultati |
Titolo del prodotto
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?